SELLAS Life Sciences (SLS) Cash from Investing Activities (QoQ) (2010 - 2017)
SELLAS Life Sciences (SLS) Cash from Investing Activities (QoQ) (2010 - 2017) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | SELLAS Life Sciences | 1.89 Bn | 1.78 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 48,532.00% |
| Sep 30, 2017 | 457.14% |
| Jun 30, 2017 | 61.11% |
| Mar 31, 2017 | 77.22% |
| Jun 30, 2016 | 199.43% |
| Mar 31, 2016 | -109.89% |
| Dec 31, 2015 | 4,405.24% |
| Sep 30, 2015 | -1,450.00% |
| Jun 30, 2015 | 11.11% |
| Mar 31, 2015 | -100.61% |
| Dec 31, 2014 | 195.84% |
| Sep 30, 2014 | -885.58% |
| Jun 30, 2014 | 84.65% |
| Mar 31, 2014 | 27.53% |
| Dec 31, 2013 | -489.44% |
| Sep 30, 2013 | 449.62% |
| Jun 30, 2013 | 101.30% |
| Jun 30, 2011 | 487.50% |
| Mar 31, 2011 | -100.67% |
| Dec 31, 2010 | 119,080.00% |